Organon & Co. (OGN) Stock Forecast & Price Target

$18.26

-0.32 (-1.72%)

(As of 04:33 PM ET)

Organon & Co. - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 5 Analyst Ratings

Sell
1

Hold
2

Buy
2

Based on 5 Wall Street analysts who have issued ratings for Organon & Co. in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 1 has given a sell rating, 2 have given a hold rating, 1 has given a buy rating, and 1 has given a strong buy rating for OGN.

Consensus Price Target

$21.00
15.01% Upside

According to the 5 analysts' twelve-month price targets for Organon & Co., the average price target is $21.00. The highest price target for OGN is $24.00, while the lowest price target for OGN is $19.00. The average price target represents a forecasted upside of 15.01% from the current price of $18.26.

Get the Latest News and Ratings for OGN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Organon & Co. and its competitors.

OGN Analyst Ratings Over Time

Type	Current Forecast 10/4/23 to 10/3/24	1 Month Ago 9/4/23 to 9/3/24	3 Months Ago 7/6/23 to 7/5/24	1 Year Ago 10/4/22 to 10/4/23
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$21.00	$22.60	$22.60	$28.25
Forecasted Upside	15.01% Upside	2.36% Upside	12.38% Upside	73.10% Upside
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Hold

Retire off just one stock ticker? (Ad)

ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else. It's currently trading for only $15...

Click here for the ticker >>>

OGN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

OGN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Organon & Co. Stock vs. The Competition

Type	Organon & Co.	Medical Companies	S&P 500
Consensus Rating Score	2.40	2.78	2.50
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	14.50% Upside	839.28% Upside	7.66% Upside
News Sentiment Rating	Positive News See Recent OGN News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/18/2024	Evercore ISI 2 of 5 stars	U. Raffat Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
9/6/2024	JPMorgan Chase & Co. 3 of 5 stars		Downgrade	Neutral ➝ Underweight	$18.00 ➝ $20.00	-6.37%
5/3/2024	The Goldman Sachs Group 2 of 5 stars		Boost Target	Neutral ➝ Neutral	$18.00 ➝ $20.00	+2.56%
4/29/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$22.00 ➝ $24.00	+29.38%
10/12/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$23.00 ➝ $19.00	+10.34%
10/11/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$27.00 ➝ $22.00	+27.39%
9/21/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$28.00	+47.99%
3/15/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$33.00	+53.35%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:24 PM ET.

OGN Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Organon & Co. is $21.00, with a high forecast of $24.00 and a low forecast of $19.00.
: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organon & Co. in the last year. There is currently 1 sell rating, 2 hold ratings, 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OGN, but not buy additional shares or sell existing shares.
: According to analysts, Organon & Co.'s stock has a predicted upside of 15.01% based on their 12-month stock forecasts.
: Over the previous 90 days, Organon & Co.'s stock had 1 upgrade and 1 downgrade by analysts.
: Organon & Co. has been rated by research analysts at Evercore ISI, and JPMorgan Chase & Co. in the past 90 days.
: Analysts like Organon & Co. less than other "medical" companies. The consensus rating for Organon & Co. is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OGN compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

44-year Wall Street Vet: “Permanent devastation is coming to America” (Ad)

After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. But now a looming disaster is threatening America. And it's unlike anything we've ever experienced before.

The information in this video is crucially valuable.

This page (NYSE:OGN) was last updated on 10/3/2024 by MarketBeat.com Staff

From Our Partners